Experience
Kaken Pharmaceutical Co., Ltd.
Zydus Pharmaceuticals (USA) Inc.
Represents Kaken in patent infringement litigation concerning multiple ANDAs for generic versions of Jublia.
Kaken Pharmaceutical Co., Ltd. v. Zydus Pharmaceuticals (USA) Inc., 3:18-cv-13635, D.N.J., Judges Sheridan, Goodman
Amarin Pharms. Ireland Ltd. v. Omthera Pharms., Inc.
Omthera Pharmaceuticals, Inc.; AstraZeneca Pharmaceuticals LP
BTG Inc., Ltd v. Actavis Labs FL Inc.; Amneal Pharms LLC
BTG Inc., Ltd.
Valeant Pharmaceuticals NA, LLC v. Zydus Pharmaceuticals, Inc.
Valeant Pharmaceuticals NA, LLC
Otsuka Pharmaceutical Co., Ltd. v. Teva Pharmaceuticals USA, Inc.
Otsuka Pharmaceutical Co.
Medicis Pharmaceutical Corp. v. Zydus Pharmaceuticals (USA) Inc.
Medicis Pharmaceutical Corp.
Valeant Pharmaceuticals North America, LLC v. Actavis, Inc.
Valeant Pharmaceuticals North America, LLC
Si-Flash Drives, LLC v. ADATA Technology (USA) Co., Ltd.
ADATA Technology (U.S.A.) Co., Ltd.
USB Technologies, LLC v. ADATA Technology USA Co., Ltd.
ADATA Technology USA Co., Ltd.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.